Christian Rommel's most recent trade in CRISPR Therapeutics AG was a trade of 13,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CRISPR Therapeutics AG | Dr. Christian Rommel, PhD | Director | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | ||
| CRISPR Therapeutics AG | Dr. Christian Rommel, PhD | Director | 05 Jun 2025 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | ||
| CRISPR Therapeutics AG | Dr. Christian Rommel, PhD | Director | 30 May 2024 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) |